Prof Freddie Hamdy, MD, FRCSEd (Urol)
Director, Division of Surgery and Oncology, Oxford University Hospitals NHS Trust
Nuffield Professor of Surgery, Oxford University
Head, Nuffield Department of Surgical Sciences
Professor of Urology & Honorary Consultant Urological Surgeon, Oxford University
Prof Hamdy joined Oxford in October 2008 as Nuffield Professor of Surgery and Head of the Nuffield Department of Surgical Sciences, Professor of Urology and Honorary Consultant Urological Surgeon at theOxford University Hospitals, as well as Fellow of Balliol College. In November 2010, he was appointed Director of the Division of Surgery and Oncology at the Oxford University Hospitals NHS Trust. This is one of OUHTs largest Divisions with approximately 1400 staff, encompassing a range of surgical and oncological activities with additional specialties such as Haematology and Gastroenterology. He was previously founding Chair of Urology and Director of the Division of Clinical Sciences, then Head of Oncology at the University of Sheffield. He obtained his primary medical degree from the University of Alexandria, Egypt, and trained in Surgery and Urology at Liverpool, Sheffield andNewcastle.
His research activities encompass clinical, translational and basic science programmes on the biology of prostate and bladder cancer. He is Principal/ Chief Investigator of many studies including ProtecT (Prostate testing for cancer and Treatment) – a study of case-finding and randomised controlled trial of treatment effectiveness in prostate cancer – the largest of its kind worldwide, funded by HTA NIHR.
Prof Hamdy was the first recipient of the Crystal Matula award from the European Association of Urology in 1996, the Golden Telescope award from the British Association of Urological Surgeons in 2002, and St Peter’s Medal from the same association in 2012. He was Chairman of the Scientific Committee at the European Association of Urology between 2004-2012, and was elected Fellow of the Academy of Medical Sciences in 2007. He has authored over 230 peer-reviewed articles, and raised to date over £50m in peer-reviewed grants. He leads the Surgical Innovation and Evaluation Theme of the Oxford NIHR Biomedical Research Centre, and is co-Director of the first Surgical Intervention Trials Unit in theUK.
He has introduced robot-assisted surgery to Oxford, and established various multidisciplinary research platforms. More recently, he has secured funding with colleagues to establish a new world-leading Precision Cancer Medicine Institute on the Old Road Campus site. This will take an all-encompassing approach to patients with early stage cancer, to develop, test and implement personalised minimally invasive treatments, combined with targeted diagnosis, imaging and therapy.